Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vehreschild

Showing results (121-130 of 221) with videos related to

Pageof 23
Sort By:
Journal of Gastroenterology and Hepatology|April 9, 2020
Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?Münevver Demir, Sonja Lang, Anna Martin, et al.
International Journal of Molecular Sciences|October 13, 2021
The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory FailureRuth P Duecker, Elisabeth H Adam, Sarah Wirtz, et al.
Scientific Reports|June 10, 2024
Differential radiological features of patients infected or colonised with slow-growing non-tuberculous mycobacteriaTeodora Biciusca, Ann-Sophie Zielbauer, Thomas Anton, et al.
Plos One|November 25, 2020
Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancerJan A Stratmann, Raphael Lacko, Olivier Ballo, et al.
Nutrition Research (New York, N.Y.)|September 26, 2022
Dietary omega-6/omega-3 ratio is not associated with gut microbiota composition and disease severity in patients with nonalcoholic fatty liver diseaseKathrin Heinzer, Sonja Lang, Fedja Farowski, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 13, 2014
Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazoleS M Heimann, O A Cornely, H Wisplinghoff, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2020
Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantationSarah Weber, Sebastian Scheich, Aaron Magh, et al.
The Lancet. Infectious Diseases|December 24, 2017
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trialBenoit Guery, Francesco Menichetti, Veli-Jukka Anttila, et al.
Plos One|July 13, 2021
Disseminated disease due to non-tuberculous mycobacteria in HIV positive patients: A retrospective case control studyNils Wetzstein, Ari Geil, Gerrit Kann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2016
A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patientsL M Biehl, A Huth, J Panse, et al.
Pageof 23

Showing results (121-130 of 221) with videos related to

Sort By:
Pageof 23
Journal of Gastroenterology and Hepatology|April 9, 2020
Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?Münevver Demir, Sonja Lang, Anna Martin, et al.
International Journal of Molecular Sciences|October 13, 2021
The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory FailureRuth P Duecker, Elisabeth H Adam, Sarah Wirtz, et al.
Scientific Reports|June 10, 2024
Differential radiological features of patients infected or colonised with slow-growing non-tuberculous mycobacteriaTeodora Biciusca, Ann-Sophie Zielbauer, Thomas Anton, et al.
Plos One|November 25, 2020
Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancerJan A Stratmann, Raphael Lacko, Olivier Ballo, et al.
Nutrition Research (New York, N.Y.)|September 26, 2022
Dietary omega-6/omega-3 ratio is not associated with gut microbiota composition and disease severity in patients with nonalcoholic fatty liver diseaseKathrin Heinzer, Sonja Lang, Fedja Farowski, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 13, 2014
Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazoleS M Heimann, O A Cornely, H Wisplinghoff, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2020
Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantationSarah Weber, Sebastian Scheich, Aaron Magh, et al.
The Lancet. Infectious Diseases|December 24, 2017
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trialBenoit Guery, Francesco Menichetti, Veli-Jukka Anttila, et al.
Plos One|July 13, 2021
Disseminated disease due to non-tuberculous mycobacteria in HIV positive patients: A retrospective case control studyNils Wetzstein, Ari Geil, Gerrit Kann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2016
A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patientsL M Biehl, A Huth, J Panse, et al.
Pageof 23